CORRECTION article

Front. Immunol., 23 June 2025

Sec. Inflammation

Volume 16 - 2025 | https://doi.org/10.3389/fimmu.2025.1637511

This article is part of the Research TopicCholesterol, inflammation and immunityView all 7 articles

Correction: Protein carbamylation in atherosclerotic plaques correlates with uremia and disease progression, localizing predominantly to foam cells

This article is a correction to:

  1. Plaque Protein Carbamylation Is Associated with Atherosclerosis Progression and Uremia and Accumulates in Foam Cells

    1. Read original article
Valeria Saar-KovrovValeria Saar-Kovrov1Aleksandra PawlowskaAleksandra Pawlowska1Adrien GuillotAdrien Guillot2Marion J. J. Gijbels,,Marion J. J. Gijbels1,3,4Judith C. Sluimer,Judith C. Sluimer1,5Lieve TemmermanLieve Temmerman1Pieter GoossensPieter Goossens1Barend M. E. MeesBarend M. E. Mees6Frank TackeFrank Tacke2Vera JankowskiVera Jankowski7Joachim Jankowski,Joachim Jankowski1,7Marjo M. P. C. DonnersMarjo M. P. C. Donners1Erik A. L. Biessen,*Erik A. L. Biessen1,7*
  • 1Department of Pathology, Cardiovascular Research Institute Maastricht, Maastricht University Medical Center, Maastricht, Netherlands
  • 2Department of Hepatology and Gastroenterology, Charité - Universitätsmedizin Berlin, Campus Virchow-Klinikum and Campus Charité Mitte, Berlin, Germany
  • 3School for Oncology and Developmental Biology (GROW), Maastricht University Medical Center, Maastricht, Netherlands
  • 4Department of Medical Biochemistry, Experimental Vascular Biology, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, Netherlands
  • 5Centre for Cardiovascular Science, University of Edinburgh, Edinburgh, United Kingdom
  • 6Department of Surgery, Maastricht University Medical Center (UMC)+, Maastricht, Netherlands
  • 7Institute for Molecular Cardiovascular Research (IMCAR), Rheinisch-Westfälische Technische Hochschule (RWTH) Aachen University, Aachen, Germany

A Correction on
Protein carbamylation in atherosclerotic plaques correlates with uremia and disease progression, localizing predominantly to foam cells

By Saar-Kovrov V, Pawlowska A, Guillot A, Gijbels MJJ, Sluimer JC, Temmerman L, Goossens P, Mees BME, Tacke F, Jankowski V, Jankowski J, Donners MMPC and Biessen EAL (2025) Front. Immunol. 16:1532250. doi: 10.3389/fimmu.2025.1532250

In the published article, there was an error in the Funding statement. The funding mentioned “This project has received funding from the European Union’s Horizon 2020 research and innovation programme under the Marie Skłodowska-Curie grant agreement No 764474 (CaReSyAn).” was incomplete. The correct Funding statement appears below.

“This project has received funding from the European Union’s Horizon 2020 research and innovation programme under the Marie Skłodowska-Curie grant agreement No 764474 (CaReSyAn). VJankowski and JJankowski are funded by the German Research Foundation (DFG) through the Transregional Collaborative Research Center (TRR 219; Project ID 322900939), (subproject S-03), (INST 948/4S-1); CRU 5011 project number 445703531, Cost-Action CA 21165, IZKF Multiorgan complexity in Friedreich Ataxia, and Phase Transition in Disease 1-1), ERA-PerMed (ERA-PERMED2022-202-KidneySign).”

The original article has been updated.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Keywords: atherosclerosis, macrophages, foam cells, carbamylation, kidney disease

Citation: Saar-Kovrov V, Pawlowska A, Guillot A, Gijbels MJJ, Sluimer JC, Temmerman L, Goossens P, Mees BME, Tacke F, Jankowski V, Jankowski J, Donners MMPC and Biessen EAL (2025) Correction: Protein carbamylation in atherosclerotic plaques correlates with uremia and disease progression, localizing predominantly to foam cells. Front. Immunol. 16:1637511. doi: 10.3389/fimmu.2025.1637511

Received: 29 May 2025; Accepted: 05 June 2025;
Published: 23 June 2025.

Approved by:

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Copyright © 2025 Saar-Kovrov, Pawlowska, Guillot, Gijbels, Sluimer, Temmerman, Goossens, Mees, Tacke, Jankowski, Jankowski, Donners and Biessen. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Erik A. L. Biessen, ZXJpay5iaWVzc2VuQG11bWMubmw=

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.